Systemic lupus erythematosus Trials in Székesfehérvár, Hungary
Conditions / Systemic lupus erythematosus / Székesfehérvár, Hungary
Clinical trials for Systemic lupus erythematosus investigate a range of treatment strategies and patient populations.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03843125 | A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) | TERMINATED | PHASE3 |
| NCT07409181 | A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE) | RECRUITING | — |
| NCT04976322 | A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus | ENROLLING_BY_INVITATION | — |
| NCT04294667 | A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus | COMPLETED | PHASE3 |
| NCT06133972 | Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). | RECRUITING | PHASE3 |
| NCT04835441 | ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus | COMPLETED | PHASE2 |
| NCT05843643 | Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus | ACTIVE_NOT_RECRUITING | — |
| NCT04877691 | Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus | ACTIVE_NOT_RECRUITING | — |
| NCT05639114 | Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03616912 | A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus | TERMINATED | PHASE3 |